高血压中的纤维蛋白溶解酶系统。
The fibrinolytic enzyme system in hypertension.
作者信息
Bennett B, Ogston D, Crawford G P, Douglas A S
出版信息
J Clin Pathol. 1973 May;26(5):351-3. doi: 10.1136/jcp.26.5.351.
Abstract
Fibrinogen, fibrinogen-related antigen (FR-antigen), and components of the fibrinolytic enzyme system were measured in patients with essential hypertension, renal disease with and without hypertension, and normal subjects. Essential hypertension was associated with a decrease in plasminogen activator and an increase in FR-antigen. In renal disease these changes were accompanied by increases in plasminogen activation inhibitor, alpha(2)-macroglobulin, alpha(1)-antitrypsin, and fibrinogen.
摘要
对原发性高血压患者、伴有或不伴有高血压的肾病患者以及正常受试者进行了纤维蛋白原、纤维蛋白原相关抗原（FR抗原）和纤溶酶系统成分的检测。原发性高血压与纤溶酶原激活物减少及FR抗原增加有关。在肾病中，这些变化伴有纤溶酶原激活抑制剂、α2-巨球蛋白、α1-抗胰蛋白酶和纤维蛋白原的增加。
相似文献
1
The fibrinolytic enzyme system in hypertension.高血压中的纤维蛋白溶解酶系统。
J Clin Pathol. 1973 May;26(5):351-3. doi: 10.1136/jcp.26.5.351.
2
The effect of age on the fibrinolytic enzyme system.年龄对纤维蛋白溶解酶系统的影响。
J Clin Pathol. 1974 Apr;27(4):326-9. doi: 10.1136/jcp.27.4.326.
3
The influence of inhibitors of plasmin and plasminogen activation on the streptokinase-induced fibrinolytic state.
Thromb Diath Haemorrh. 1970 Oct 31;24(1):101-12.
4
[Human thrombin inhibitors ( 2 -macroglobulin and antithrombin 3) during and after surgical and gynecologic-obstetrical intervention].手术及妇产科干预期间及之后的人凝血酶抑制剂（α2-巨球蛋白和抗凝血酶Ⅲ）
Folia Haematol Int Mag Klin Morphol Blutforsch. 1972;98(4):397-407.
5
The fibrinolytic enzyme system after trauma and in patients with fat embolism.创伤后及脂肪栓塞患者的纤溶酶系统。
J Bone Joint Surg Br. 1974 Aug;56B(3):421-6.
6
Diabetic retinopathy and the fibrinolytic system.
Diabetes. 1975 Jun;24(6):529-34.
7
The fibrinolytic enzyme system in acute and chronic liver injury.急性和慢性肝损伤中的纤维蛋白溶解酶系统。
Acta Haematol. 1974;52(5):289-93. doi: 10.1159/000208253.
8
Decreased plasma fibrinolysis in patients with rheumatoid arthritis.类风湿关节炎患者血浆纤维蛋白溶解功能降低。
Ann Rheum Dis. 1984 Dec;43(6):774-7. doi: 10.1136/ard.43.6.774.
9
Coagulation and fibrinolysis after renal transplantation.肾移植后的凝血与纤维蛋白溶解
Scand J Urol Nephrol. 1969;3(1):23-9. doi: 10.3109/00365596909135376.
10
The effeCt of vitamin c supplements on serum cholesterol, coagulation, fibrinolysis and platelet adhesiveness.维生素C补充剂对血清胆固醇、凝血、纤维蛋白溶解及血小板黏附性的影响。
Atherosclerosis. 1975 May-Jun;21(3):451-4. doi: 10.1016/0021-9150(75)90056-8.
本文引用的文献
1
A new method for the determination of fibrinogen in small samples of plasma.一种测定少量血浆样本中纤维蛋白原的新方法。
J Lab Clin Med. 1951 Feb;37(2):316-20.
2
THE COAGULATION PROCESS AND GLOMERULAR DISEASE.凝血过程与肾小球疾病
Am J Med. 1965 Aug;39:179-83. doi: 10.1016/0002-9343(65)90040-9.
3
PLASMA FIBRINOLYTIC ACTIVITY IN RENAL DISEASE.肾脏疾病中的血浆纤溶活性
Scott Med J. 1965 May;10:189-94. doi: 10.1177/003693306501000502.
4
Significance of cryoprofibrin in fibrinogen-fibrin conversion.冷沉淀纤维蛋白原在纤维蛋白原 - 纤维蛋白转化中的意义。
J Exp Med. 1962 Nov 1;116(5):687-707. doi: 10.1084/jem.116.5.687.
5
The mechanism of clot dissolution by plasmin.纤溶酶溶解血栓的机制。
J Clin Invest. 1959 Jul;38(7):1086-95. doi: 10.1172/JCI103885.
6
Studies on enhanced fibrinolytic activity in man.关于人类纤维蛋白溶解活性增强的研究。
J Clin Invest. 1959 May;38(5):810-22. doi: 10.1172/JCI103863.
7
8
Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease.健康人群与缺血性心脏病患者的血浆纤维蛋白原和纤溶酶原水平
J Clin Pathol. 1966 Jul;19(4):352-6. doi: 10.1136/jcp.19.4.352.
9
A method for the quantitative assay of inhibitor of plasminogen activation in human serum.一种定量测定人血清中纤溶酶原激活抑制剂的方法。
Thromb Diath Haemorrh. 1967 Feb 28;17(1-2):12-22.
10
Inhibitors of the fibrinolytic enzyme system in renal disease.肾脏疾病中纤维蛋白溶解酶系统的抑制剂
Clin Sci. 1970 Nov;39(5):549-57. doi: 10.1042/cs0390549.
Zotero 插件